Elevance Health, Inc. vs Humana Inc.
A head-to-head of Elevance Health, Inc. (ELV) and Humana Inc. (HUM) across valuation, profitability, growth, and dividends. Green marks the more favourable value on that metric only — not a recommendation.
| Metric | ELV | HUM |
|---|---|---|
| Market Cap | $80.92B | $48.02B |
| P/E (TTM) | 16.58 | 40.65 |
| Forward P/E | 12.58 | 20.24 |
| P/S | 0.39 | 0.27 |
| P/B | 1.80 | 4.26 |
| EV/EBITDA | 0.00 | 8.85 |
| Dividend Yield | 1.86% | 0.54% |
| Profit Margin | 2.47% | 0.82% |
| Gross Margin | 25.56% | — |
| Operating Margin | 4.07% | — |
| Revenue Growth (YoY) | +1.40% | +23.47% |
| FCF Yield | 8.19% | 3.41% |
| Debt / Equity | 68.95 | 75.05 |
| Current Ratio | 1.48 | 1.77 |
Which is better: Elevance Health, Inc. or Humana Inc.?
- ✓Larger by market cap: Elevance Health, Inc.
- ✓Cheaper valuation (lower P/E): Elevance Health, Inc.
- ✓Higher dividend yield: Elevance Health, Inc.
- ✓More profitable (net margin): Elevance Health, Inc.
- ✓Faster revenue growth: Humana Inc.
- ✓Higher free-cash-flow yield: Elevance Health, Inc.
Across 10 available metrics, Elevance Health, Inc. leads 7–3.
There's no single "better" — it depends on your goal: income investors may prefer the higher yield, growth investors the faster grower, and value investors the cheaper one. See each stock's page for deeper detail. This is an automated read, not a recommendation.
Share:
This comparison is for informational and educational purposes only, based on available data — not a recommendation to buy or sell any stock.